CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Planned sale Chief Legal Officer sold 117 shares at $94.34 ($11,038)
- 4 Planned sale President sold 309 shares at $94.34 ($29,151)
- 4 Planned sale Chief Financial Officer sold 647 shares at $94.57 ($61,188)
- 4 Planned sale Chief Legal Officer sold 670 shares at $94.57 ($63,363)
- 4 Planned sale President sold 2,388 shares at $94.57 ($225,838)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President sold 15,000 shares at $100.00 ($1,500,000)
- 4 Planned sale President sold 10,542 shares at $88.88 ($936,981)
- 4 Planned sale Chief Executive Officer sold 26,351 shares at $88.88 ($2,342,098)
- 4 Planned sale President sold 304 shares at $86.23 ($26,214)
- 4 Planned sale President sold 15,000 shares at $103.90 ($1,558,500)
- 4 Planned sale Chief Financial Officer sold 772 shares at $109.75 ($84,731)
- 4 Planned sale President sold 45,000 shares at $100.01 ($4,500,450)
- 4 Planned sale Chief Legal Officer sold 563 shares at $79.09 ($44,525)
- 4 Planned sale Chief Commercial Officer sold 564 shares at $78.34 ($44,182)
- 4 Planned sale Chief Legal Officer sold 111 shares at $79.31 ($8,804)
- 4 Planned sale President sold 309 shares at $79.31 ($24,508)
Page 10 of 54 · 1,067 filings